Suppr超能文献

眼皮肤白化病 1B 型与全外显子测序检测到的具有功能意义的酪氨酸酶基因突变相关。

Oculocutaneous albinism type 1B associated with a functionally significant tyrosinase gene polymorphism detected with Whole Exome Sequencing.

机构信息

Centro Nacional de Genética Médica "Dr. Eduardo E. Castilla", ANLIS, Buenos Aires, Argentina.

Center for Development of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.

出版信息

Ophthalmic Genet. 2021 Jun;42(3):291-295. doi: 10.1080/13816810.2021.1888129. Epub 2021 Feb 18.

Abstract

: Oculocutaneous albinism (OCA) is a Mendelian disorder characterized by hypopigmentation of the skin, hair, and eyes, hypoplastic fovea, and low vision, known to be caused by mutations in the Tyrosinase (TYR) gene. Among the known TYR variants, some reduce but do not completely eliminate tyrosinase activity, allowing residual production of melanin and resulting in a contradictory assignment as either pathogenic or benign, preventing a precise clinical diagnostic.: In the present work, we performed Whole Exome Sequencing and subsequent Sanger sequencing in a young male clinically diagnosed with OCA.: Whole-exome sequencing analysis revealed the identification of two variants in trans in TYR. The first, corresponds to a known pathogenic variant G47D, while the second S192Y, was considered a polymorphism due to its relatively high frequency in the European population.: The lack of other pathogenic variants in TYR, the reported reduced enzymatic activity (ca. 40% respect to wt) for S192Y, together with the structural in-silico analysis strongly suggest that both reported variants are jointly disease-causing and that S192Y should be considered as likely pathogenic, especially when it is found in trans with a null variant.

摘要

眼皮肤白化病(OCA)是一种孟德尔疾病,其特征是皮肤、头发和眼睛色素减退、黄斑发育不良和视力低下,已知是由酪氨酸酶(TYR)基因的突变引起的。在已知的 TYR 变体中,有些变体降低但不完全消除酪氨酸酶活性,允许残留黑色素的产生,并导致具有矛盾的致病性或良性分配,从而阻止了精确的临床诊断。

在本工作中,我们对一名临床诊断为 OCA 的年轻男性进行了全外显子组测序和随后的 Sanger 测序。

全外显子组测序分析鉴定了 TYR 中转录的两个变体。第一个对应于已知的致病性变体 G47D,而第二个 S192Y 由于其在欧洲人群中的相对高频率被认为是一种多态性。

由于 TYR 中没有其他致病性变体,报道的 S192Y 酶活性降低(约为 wt 的 40%),以及结构的计算机分析强烈表明,这两个报道的变体共同导致疾病,并且 S192Y 应该被认为是可能的致病性变体,尤其是当它与无效变体发生共转时。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验